Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.93%246.081.3%$803.28m
IMMUImmunomedics, Inc. 0.06%85.4111.0%$697.59m
MRNAModerna, Inc. 1.93%70.810.0%$679.34m
NVAXNovavax, Inc. -3.41%109.6996.5%$607.57m
ILMNIllumina, Inc. 1.09%303.163.5%$589.15m
GILDGilead Sciences, Inc. 0.82%62.761.0%$578.81m
REGNRegeneron Pharmaceuticals, Inc. -1.62%564.772.7%$436.21m
BIIBBiogen, Inc. 2.87%281.111.6%$344.57m
VRTXVertex Pharmaceuticals, Inc. -0.24%267.531.9%$340.03m
ALXNAlexion Pharmaceuticals, Inc. -0.83%113.482.0%$282.85m
EXASEXACT Sciences Corp. 3.25%100.8720.7%$265.64m
SRNESorrento Therapeutics, Inc. 6.69%10.281.5%$256.99m
SGENSeattle Genetics, Inc. 2.33%189.256.0%$217.07m
VXRTVaxart, Inc. -4.60%7.060.0%$204.06m
MNTAMomenta Pharmaceuticals, Inc. 0.09%52.453.0%$193.77m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.